Castle Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,049
Closed -$276K 129
2025
Q1
$276K Sell
3,049
-453
-13% -$42.3K 0.11% 104
2024
Q4
$351K Sell
3,502
-272
-7% -$28K 0.14% 92
2024
Q3
$431K Buy
3,774
+15
+0.4% +$1.78K 0.17% 84
2024
Q2
$468K Buy
3,759
+102
+3% +$13.1K 0.22% 79
2024
Q1
$485K Sell
3,657
-20
-0.5% -$2.46K 0.25% 82
2023
Q4
$404K Buy
3,677
+106
+3% +$11K 0.24% 89
2023
Q3
$370K Sell
3,571
-86
-2% -$9.27K 0.26% 77
2023
Q2
$425K Sell
3,657
-748
-17% -$84.9K 0.3% 72
2023
Q1
$471K Sell
4,405
-16
-0.4% -$1.73K 0.36% 62
2022
Q4
$494K Buy
4,421
+1
+0% +$102 0.31% 63
2022
Q3
$384K Sell
4,420
-99
-2% -$8.84K 0.23% 71
2022
Q2
$415K Buy
+4,519
New +$401K 0.24% 69

Other funds holding MRK

Castle Wealth Management's MRK Position: Q2 2025 in Review

Castle Wealth Management sold out of Merck (MRK) in Q2 2025, closing a stake of 3,049 shares — an estimated $276K sold.

Castle Wealth Management first reported a position in MRK in Q2 2022 and held it in 12 quarters. The position peaked at $494K in Q4 2022. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Castle Wealth Management reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Castle Wealth Management sold 3,049 Merck shares in Q2 2025, an estimated $276K.
  • Castle Wealth Management first reported a position in Merck in Q2 2022 and held it in 12 quarters.
  • Castle Wealth Management's Merck position peaked at $494K in Q4 2022.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Castle Wealth Management's 13F filing for Q2 2025, filed 30 Jul 2025.